Zinc Sulfate

CHEMBL1200929 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
161.4 g/mol
LogP
Phase
4

Zinc sulfate is an inorganic zinc salt used as an oral zinc supplement to treat and prevent zinc deficiency states, supporting wound healing, immune function, growth, and taste/smell sensation. It has been investigated in numerous conditions including the common cold (intranasal zinc), age-related macular degeneration (AREDS formulation), and Wilson's disease as an alternative zinc source for copper absorption inhibition. Topical zinc sulfate has mild astringent and antimicrobial properties used in ophthalmic solutions.

Molecular Weight

161.4000 g/mol

TPSA

88.60 Ų

Therapeutic Areas

Mechanism of Action

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=S(=O)([O-])[O-].[Zn+2]

InChI

InChI=1S/H2O4S.Zn/c1-5(2,3)4;/h(H2,1,2,3,4);/q;+2/p-2

Molecular Formula

O4SZn

HBD / HBA

- / 4

Rotatable Bonds

0

Heavy Atoms

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Zinc sulfate is an inorganic zinc salt used as an oral zinc supplement to treat and prevent zinc deficiency states, supporting wound healing, immune function, growth, and taste/smell sensation. It has been investigated in numerous conditions including the common cold (intranasal zinc), age-related macular degeneration (AREDS formulation), and Wilson's disease as an alternative zinc source for copper absorption inhibition. Topical zinc sulfate has mild astringent and antimicrobial properties used in ophthalmic solutions.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Zinc Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200929. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24424. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.